Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-21

Clinical Trial Update: 3 Month Study of Cationorm Pro Versus Vismed in Adults With Dry Eye Disease Related to Keratitis or Keratoconjunctivitis [NA]

View source ↗

Summary

A completed 3-month study comparing Cationorm Pro with Vismed in adults with dry eye disease related to keratitis or keratoconjunctivitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cationorm Pro
  • Vismed

Snippet

Sponsor: Santen SAS | Conditions: Dry Eye Syndromes | NA | Status: COMPLETED